Evidence map›Paper›PMID 30294330›Full record

ArticleFrontiers in immunology2018

The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).

Anna S Świerzko, Mateusz Michalski, Anna Sokołowska, Mateusz Nowicki, Łukasz Eppa, Agnieszka Szala-Poździej, Iwona Mitrus, Anna Szmigielska-Kapłon, Małgorzata Sobczyk-Kruszelnicka, Katarzyna Michalak and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Association Between Variants of the Mannose-Binding Lectin 2 Gene and Susceptibility to Sepsis in the Hainan Island.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  4. Article
  5. Polymorphisms of theFrontiers in immunology · 2021
    Article
  6. Article
  7. Association of Polymorphisms ofInternational journal of molecular sciences · 2020
    Review
  8. Review
  9. Article
  10. Review
  11. Effects of VEGFR1Journal of cancer research and clinical oncology · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Anna S ŚwierzkoLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Mateusz MichalskiLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Anna SokołowskaLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Mateusz NowickiDepartment of Hematology, Copernicus Memorial Hospital in Łódź Comprehensive Cancer Center and Traumatology, Łódź, Poland.
Łukasz EppaLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Agnieszka Szala-PoździejLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Iwona MitrusDepartment of Bone Marrow Transplantation and Oncohematology, Cancer Center and Institute of Oncology, Gliwice, Poland.
Anna Szmigielska-KapłonDepartment of Hematology, Medical University of Łódz, Łódź, Poland.
Małgorzata Sobczyk-KruszelnickaDepartment of Bone Marrow Transplantation and Oncohematology, Cancer Center and Institute of Oncology, Gliwice, Poland.
Katarzyna MichalakDepartment of Bone Marrow Transplantation and Oncohematology, Cancer Center and Institute of Oncology, Gliwice, Poland.
Aleksandra GołosDepartment of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Agnieszka WierzbowskaDepartment of Hematology, Medical University of Łódz, Łódź, Poland.
Sebastian GiebelDepartment of Bone Marrow Transplantation and Oncohematology, Cancer Center and Institute of Oncology, Gliwice, Poland.
Krzysztof JamroziakDepartment of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Marek L KowalskiDepartment of Immunology and Allergy, Medical University of Łódz, Łódź, Poland.
Olga BrzezińskaDepartment of Immunology and Allergy, Medical University of Łódz, Łódź, Poland.
Steffen ThielDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Jens C JenseniusDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Katarzyna KasperkiewiczDepartment of Microbiology, University of Silesia, Katowice, Poland.
Maciej CedzyńskiLaboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland.
Polish Academy of Sciences · PLMedical University of Lodz · PLAarhus University · DKInstytut Hematologii i Transfuzjologi · PLCopernicus Memorial Hospital · PLUniversity of Silesia in Katowice · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a prospective study of 312 patients (194 with multiple myeloma, 118 with lymphomas) receiving high-dose conditioning chemotherapy and autologous hematopoietic stem cell transplantation (auto-HSCT). Polymorphisms of

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsBacteremiaCase-Control StudiesChemotherapy-Induced Febrile NeutropeniaCollectinsComplement ActivationDose-Response Relationship, DrugFemaleFollow-Up StudiesGraft RejectionHealthy VolunteersHematopoietic Stem Cell TransplantationHumansAntineoplastic AgentsCollectinsMannose-Binding Protein-Associated Serine ProteasesMASP2 protein, humanCL-LKcollectincomplementhematopoietic stem cell transplantation (HSCT)lymphomamannose-binding lectin (MBL)MASPmutliple myeloma

Identifiers

PMID30294330
PMCPMC6158352
OpenAlexW2889991173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.